October 24: The Week in Cancer News
COVID vaccines may improve immunotherapy effects, and a drug combination reduces the risk for death in bladder cancer.
Progress Against Cancer
COVID vaccines may improve immunotherapy effects, and a drug combination reduces the risk for death in bladder cancer.
In October 2025, AACR's journals editors highlighted studies on the anticancer function of an Alzheimer’s-related protein, small-molecule-drug conjugates, and more.
Frank McCormick, PhD, FAACR, reflected on a career chasing the notorious RAS oncogene that earned him the inaugural Stephenson Global Prize.
For September 2025, the editors of AACR's journals highlighted studies on cervical cancer screening, supercharging immunotherapy, and more.
Researchers are helping advance ovarian cancer care with breakthroughs that are reshaping treatment and early detection approaches.
New research is redefining the role of surgery, revealing approaches to help cancer patients preserve their organs, function, and identity without compromising outcomes.
New research highlights approaches that could provide better long-term quality of life for childhood cancer survivors into adulthood.
Some people’s cancer treatment may not align with their care goals, and a blood test may detect ovarian cancer at early stages.
For August 2025, the editors of AACR's journals highlighted studies on liquid biopsy for brain cancer, new treatment strategies for prostate and colorectal cancers, and more.
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More